HOME >> BIOLOGY >> NEWS
Experimental Drug Derived From Snake Venom Shows Promise In Reversing Effects Of Stroke

NASHVILLE, Feb. 4 -- A stroke therapy derived from snake venom? According to researchers, it's not a snake oil story, but instead a possible new way to help people recover from the devastating effects of stroke.

Scientists announced the results of a 500-person trial examining the effects of an experimental stroke drug called ANCROD here today at the 24th American Heart Association International Conference on Stroke and Cerebral Circulation.

Researchers found that 42 percent of stroke victims treated with ANCROD within three hours of stroke onset had recovered the physical and mental abilities that they had prior to the stroke.

In comparison, 34 percent of those receiving an inert substance, or placebo, regained their previous faculties. However, stroke patients who received ANCROD were also at a higher risk of bleeding in the brain (5 percent of patients) when compared to those who received the placebo (2 percent).

ANCROD is not yet approved by the Food and Drug Administration for stroke treatment. Tissue plasminogen activator (TPA) is the only FDA-approved acute stroke treatment.

ANCROD is derived from the venom of a pit viper snake. Researchers discovered that in people who were bitten by the snake, blood failed to clot. Based on that observation, the venom was utilized as an anticoagulant, helping blood flow more freely through vessels.

"Like clot-dissolving drugs TPA and urokinase, the goal was for ANCROD to be administered within three hours of stroke onset," says the study's lead author, David Sherman, M.D. "Also, none of these three drugs are for use in patients who have hemorrhagic strokes, caused by a burst or leaking blood vessel in the brain."

There are sharp contrasts between the treatments, however, says Sherman.

TPA is administered in a single-dose, hour-long injection and results can be seen soon thereafter. ANCROD is given intravenously through
'"/>

Contact: Brian Henry or Cathy Yarbrough
615-231-1601
American Heart Association
4-Feb-1999


Page: 1 2 3

Related biology news :

1. Experimental drug shown to block mutant protein causing blood disease
2. Experimental smallpox DNA vaccine protects primates from lethal monkeypox
3. Experimental smallpox vaccine protects against monkeypox in nonhuman primates
4. Experimental Biology 2004 - Translating the Genome
5. Experimental Biology 2004 meets in Washington, D.C. April 17-21
6. Experimental hantavirus vaccine elicits strong antibody response in primates
7. Experimental cancer drugs may halt events that lead to cardiac hypertrophy and heart failure
8. Experimental Biology 2003 meets in San Diego April 11-15
9. Experimental Biology 2003 meets in San Diego April 11-15
10. Experimental gene switch increases lifespan with no ill effects
11. Experimental therapy stops allergic reactions in mice

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/19/2020)... ... June 18, 2020 , ... ... Your Lab with Software for Data Decisions,” for pharmaceutical and biotech executives, ... integrate and automate cutting-edge scientific instruments and laboratory equipment from dozens of ...
(Date:6/5/2020)... (PRWEB) , ... June 04, 2020 , ... Murrieta ... filed a new patent application for simplified sample preparation for Next Generation Genomic ... will greatly reduce cost, time, and complexity of sample preparation. , “I have been ...
(Date:5/28/2020)... ... 27, 2020 , ... CrucialTrak, a global designer and manufacturer of biometric access ... (CEG) to market and sell its complete line of biometric readers and access ... infrastructure optimization solutions . , Brett Mason, CrucialTrak’s Director of Channel Sales for ...
Breaking Biology News(10 mins):
(Date:6/11/2020)... ... ... Reducing carbon emissions has been and will continue to be a major ... ways to reduce CO2 is something we can’t avoid. , To protect the ... produced today are created from recycled cooking oil or crops. Unfortunately, these sources are ...
(Date:6/2/2020)... ... June 01, 2020 , ... As ... encourage positive change in the world, enterprise security solutions provider bitsIO donated time ... people working from home during self-quarantines and shelter-in-place orders, companies are increasingly concerned ...
(Date:5/30/2020)... ... May 29, 2020 , ... The Conference Forum ... newsletter solely dedicated to the unique role of the Chief Medical Officer in ... the responsibilities, problem-solving, best practices and career development of CMOs and Heads of ...
(Date:5/28/2020)... SPRING, Md. (PRWEB) , ... May 28, 2020 , ... ... distinguished biometrics and security leaders as the 2020 winners of the Women in ... co-presented with sponsors IDEMIA , Biometric Update and the SIA ...
Breaking Biology Technology:
Cached News: